Belarus vs Small island developing states (SIDS): Proportion of the target population who received
Belarus
98.0%
in 2024
Small island developing states (SIDS)
63.0%
in 2024
Belarus rank
14th
Small island developing states (SIDS) rank
16th
Proportion of the target population who received over time
- Belarus
- Small island developing states (SIDS)
How they compare
Belarus currently reports 98.0% against 63.0% in Small island developing states (SIDS), a difference of 35.0%.
That makes Belarus's figure about 1.6 times Small island developing states (SIDS)'s.
Across all 25 years both countries report, Belarus has been ahead every year.
Belarus ranks 14th and Small island developing states (SIDS) ranks 16th of 165 countries.
Belarus has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Belarus | Small island developing states (SIDS) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 97.3% | 19.6% | 77.7% | Belarus |
| 2010s | 98.3% | 31.6% | 66.7% | Belarus |
| 2020s | 97.4% | 56.8% | 40.6% | Belarus |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received, Belarus or Small island developing states (SIDS)?
- Belarus, at 98.0% against 63.0% in Small island developing states (SIDS) as of 2024.
- What is the difference in proportion of the target population who received between Belarus and Small island developing states (SIDS)?
- 35.0%, with Belarus ahead.
- How many years of comparable data are there for Belarus and Small island developing states (SIDS)?
- 25 years are reported by both, from 2000 to 2024.
- How do Belarus and Small island developing states (SIDS) rank globally for proportion of the target population who received?
- Belarus ranks 14th and Small island developing states (SIDS) ranks 16th of 165 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.